Interleukin-2-triggered Raf-1 expression, phosphorylation, and associated kinase activity increase through G1 and S in CD3-stimulated primary human T cells

Mol Cell Biol. 1991 May;11(5):2794-803. doi: 10.1128/mcb.11.5.2794-2803.1991.

Abstract

To gain further insight into the role of Raf-1 in normal cell growth, c-raf-1 mRNA expression, Raf-1 protein production, and Raf-1-associated kinase activity in normal human T cells were analyzed. In contrast to the constitutive expression of Raf-1 in continuously proliferating cell lines, c-raf-1 mRNA and Raf-1 protein levels were barely detectable in freshly isolated G0 T lymphocytes. Previous work with fibroblasts has suggested that Raf-1 plays a signaling role in the G0-G1 phase transition. In T cells, triggering via the T-cell antigen receptor (TCR)-CD3 complex (TCR/CD3) resulted in an approximately fourfold increase in c-raf-1 mRNA. In addition, the promotion of G1 progression by interleukin 2 (IL-2) was associated with a 5- to 10-fold immediate/early induction of c-raf-1 mRNA, resulting in up to a 12-fold increase in Raf-1 protein expression. TCR/CD3 activation did not alter the phosphorylation state of Raf-1, whereas interleukin 2 receptor stimulation resulted in a rapid increase in the phosphorylation state of a subpopulation of Raf-1 molecules progressively increasing throughout G1. These findings were complemented by assays for Raf-1-associated kinase activity which revealed a gradual accumulation of serine and threonine autokinase activity in Raf-1 immunoprecipitates during G1, which remained elevated throughout DNA replication.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antigens, CD / physiology*
  • Antigens, Differentiation, T-Lymphocyte / physiology*
  • Blotting, Northern
  • Blotting, Western
  • CD3 Complex
  • Cell Cycle*
  • Cells, Cultured
  • Cycloheximide / pharmacology
  • Cyclosporins / pharmacology
  • Gene Expression / drug effects
  • Humans
  • Interleukin-2 / pharmacology*
  • Phosphorylation
  • Plasmids
  • Protein-Tyrosine Kinases / genetics
  • Protein-Tyrosine Kinases / metabolism
  • Proto-Oncogene Proteins / genetics*
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-raf
  • Proto-Oncogenes*
  • RNA / genetics
  • RNA / isolation & purification
  • RNA, Messenger / drug effects
  • RNA, Messenger / genetics*
  • Receptors, Antigen, T-Cell / physiology*
  • Resting Phase, Cell Cycle
  • S Phase
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology
  • T-Lymphocytes / physiology*
  • Transcription, Genetic / drug effects*

Substances

  • Antigens, CD
  • Antigens, Differentiation, T-Lymphocyte
  • CD3 Complex
  • Cyclosporins
  • Interleukin-2
  • Proto-Oncogene Proteins
  • RNA, Messenger
  • Receptors, Antigen, T-Cell
  • RNA
  • Cycloheximide
  • Protein-Tyrosine Kinases
  • Proto-Oncogene Proteins c-raf